Trademark: 78629724
Status Date
Wednesday, August 11, 2021
Registration Number
3960628
Registration Date
Tuesday, May 17, 2011
Filing Date
Friday, May 13, 2005
Published for Opposition
Tuesday, March 1, 2011
1 Chemical, biochemical and biotechnical products for industrial and scientific purposes, namely, solutions for protein processing, protease inhibitor solutions, detergent solutions, buffers, reagents, [ resins, enzymes, proteins, ] and solvents for scientific, research, or industrial use; [ biotechnological products, namely, solutions for protein processing, protease inhibitor solutions, detergent solutions, buffers, reagents, resins, enzymes, proteins, and solvents, in particular for performing separation, isolation and/or purification methods for biopolymers, in particular proteins, macromolecules and biologically active substances for diagnostic purposes; diagnostic preparations, except for use in human medicine and veterinary medicine; chemical reagents and solvents except those for purposes in human medicine and veterinary medicine to perform separation, isolation, and/or purification methods for biopolymers, in particular for proteins, macromolecules and biologically active substances; ] kits comprising chemical products, namely, solutions for protein processing, protease inhibitors solutions, detergent solutions, buffers, reagents,[ resins, enzymes, proteins, ] and solvents, for the separation and isolation and/or purification of biopolymers, in particular proteins, macromolecules and biologically active substances, in particular proteins from biological material; [ cell compartment kits containing extraction buffers and reagents for scientific use; nuclear protein kits containing buffers for isolation and fractionation of nucleic acid binding proteins for scientific use; nuclear subfractionation kits containing buffers for isolation and fractionation of nucleic acid binding proteins for scientific use; total glycoprotein kits containing buffers and reagents for scientific use; mannose glycoprotein kits containing buffers and reagents for scientific use; sialic glycoprotein kits containing buffers and reagents for scientific use; o-glycan glycoprotein kits containing buffers and reagents for scientific use; ] mitochondria isolation kits containing buffers and reagents for isolation of high-purity mitochondria preparations for scientific use [ ; plasma membrane protein kits containing buffers and reagents for isolation of plasmamembrane proteins for scientific use; glycoarray kits containing buffers and reagents for scientific use; albumin/IgG depletion kits containing buffers and reagents for scientific use; murine albumin depletion kits containing buffers and reagents for scientific use; bacterial protein prep kits containing buffers and reagents for scientific use; mammalian protein prep kits containing buffers and reagents for scientific use; collection tubes and columns for analysis of glycan makeup and glycoproteins for scientific use ]
5 [ Diagnostic preparations and products for use in human medicine and veterinary medicine, namely, solutions for protein processing, protease inhibitor solutions, detergent solutions, buffers, reagents, resins, enzymes, proteins, and solvents for the separation, isolation and purification of biopolymers, in particular of proteins, macromolecules and biologically active substances; chemical, biochemical products, namely, solutions for protein processing, protease inhibitor solutions, detergent solutions, buffers, reagents, resins, enzymes, proteins, and solvents, in particular for performing separation, isolation and/or purification methods for biopolymers, in particular proteins, macromolecules and biologically active substances for medical diagnostic purposes; kits comprising products for medical or veterinary medical diagnostic purposes, namely, solutions for protein processing, protease inhibitor solutions, detergent solutions, buffers, reagents, resins, enzymes, proteins, and solvents, in particular for separation, isolation and/or purification of biopolymers, in particular of proteins, macromolecules and biological active substances, in particular of proteins from biological material; cell compartment kits containing extraction buffers and reagents for medical use; nuclear protein kits containing buffers for isolation and fractionation of nucleic acid binding proteins for medical use; nuclear subfractionation kits containing buffers for isolation and fractionation of nucleic acid binding proteins for medical use; total glycoprotein kits containing buffers and reagents for medical use; mannose glycoprotein kits containing buffers and reagents for medical use; sialic glycoprotein kits containing buffers and reagents for medical use; o-glycan glycoprotein kits containing buffers and reagents for medical use; mitochondria isolation kits containing buffers and reagents for isolation of high-purity mitochondria preparations for medical use; plasma membrane protein kits containing buffers and reagents for isolation of plasmamembrane proteins for medical use; glycoarray kits containing buffers and reagents for medical use; albumin/IgG depletion kits containing buffers and reagents for medical use; murine albumin depletion kits containing buffers and reagents for medical use; bacterial protein prep kits containing buffers and reagents for medical use; mammalian protein prep kits containing buffers and reagents for medical use; collection tubes and columns for analysis of glycan makeup and glycoproteins for medical use ]
9 [ Scientific apparatus, instruments and equipment, namely, binding supports, crystallization supports, columns, tube extenders, collection tubes, and cartridge filters; optical apparatuses and instruments for use in protein processing; calculating machines; electrical and electronic apparatuses and instruments for research and examination purposes for use in protein processing; laboratory equipment, measuring apparatus and instruments for medical or veterinary medical diagnostic purposes, for the separation, purification, and/or isolation of biopolymers, macromolecules and biological active substances and proteins from biological material, namely, soluble protein separation kits containing buffers and reagents for the preparation of separate protein fractions from cleared cell lysates; related computer software for analysis of glycan makeup and glycoproteins ]
Aug 11, 2021
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Aug 11, 2021
Registered And Renewed (First Renewal - 10 Yrs)
Aug 11, 2021
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Aug 10, 2021
Case Assigned To Post Registration Paralegal
Apr 22, 2021
Teas Section 8 & 9 Received
May 17, 2020
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Jun 10, 2017
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jun 10, 2017
Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jun 9, 2017
Case Assigned To Post Registration Paralegal
Apr 20, 2017
Teas Section 8 & 15 Received
May 17, 2016
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 17, 2011
Registered-Principal Register
Mar 1, 2011
Official Gazette Publication Confirmation E-Mailed
Mar 1, 2011
Published For Opposition
Jan 21, 2011
Law Office Publication Review Completed
Jan 14, 2011
Approved For Pub - Principal Register
Jan 14, 2011
Teas/Email Correspondence Entered
Jan 14, 2011
Correspondence Received In Law Office
Jan 14, 2011
Teas Response To Office Action Received
Nov 3, 2010
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 3, 2010
Assigned To Lie
Oct 18, 2010
Paper Received
Oct 1, 2010
Notification Of Non-Final Action E-Mailed
Oct 1, 2010
Non-Final Action E-Mailed
Oct 1, 2010
Non-Final Action Written
Sep 8, 2010
Teas/Email Correspondence Entered
Sep 8, 2010
Correspondence Received In Law Office
Sep 8, 2010
Teas Response To Office Action Received
Jul 28, 2010
Notification Of Priority Action E-Mailed
Jul 28, 2010
Priority Action E-Mailed
Jul 28, 2010
Priority Action Written
Jul 8, 2010
Teas/Email Correspondence Entered
Jul 8, 2010
Correspondence Received In Law Office
Jul 8, 2010
Teas Response To Office Action Received
Jun 7, 2010
Notification Of Non-Final Action E-Mailed
Jun 7, 2010
Non-Final Action E-Mailed
Jun 7, 2010
Non-Final Action Written
May 13, 2010
Teas/Email Correspondence Entered
May 13, 2010
Correspondence Received In Law Office
May 13, 2010
Teas Response To Office Action Received
Dec 5, 2009
Notification Of Non-Final Action E-Mailed
Dec 5, 2009
Non-Final Action E-Mailed
Dec 5, 2009
Non-Final Action Written
Nov 4, 2009
Teas/Email Correspondence Entered
Nov 4, 2009
Correspondence Received In Law Office
Nov 4, 2009
Teas Response To Office Action Received
Jun 26, 2009
Undeliverable Mail - Courtesy Copy Mailed
Jun 25, 2009
Notification Of Non-Final Action E-Mailed
Jun 25, 2009
Non-Final Action E-Mailed
Jun 25, 2009
Non-Final Action Written
Jun 1, 2009
Previous Allowance Count Withdrawn
May 31, 2009
Withdrawn From Pub - Og Review Query
May 18, 2009
Law Office Publication Review Completed
May 18, 2009
Approved For Pub - Principal Register
May 1, 2009
Teas/Email Correspondence Entered
Apr 30, 2009
Correspondence Received In Law Office
Apr 30, 2009
Teas Response To Office Action Received
Jan 12, 2009
Notification Of Non-Final Action E-Mailed
Jan 12, 2009
Non-Final Action E-Mailed
Jan 12, 2009
Non-Final Action Written
Nov 28, 2008
Previous Allowance Count Withdrawn
Nov 21, 2008
Withdrawn From Pub - Og Review Query
Nov 12, 2008
Law Office Publication Review Completed
Nov 11, 2008
Approved For Pub - Principal Register
Oct 16, 2008
Amendment From Applicant Entered
Oct 16, 2008
Correspondence Received In Law Office
Oct 9, 2008
Paper Received
Apr 8, 2008
Notification Of Non-Final Action E-Mailed
Apr 8, 2008
Non-Final Action E-Mailed
Apr 8, 2008
Non-Final Action Written
Jan 15, 2008
Amendment From Applicant Entered
Jan 15, 2008
Correspondence Received In Law Office
Jan 7, 2008
Paper Received
Jul 2, 2007
Undeliverable Mail - Courtesy Copy Mailed
Jul 2, 2007
Notification Of Non-Final Action E-Mailed
Jul 2, 2007
Non-Final Action E-Mailed
Jul 2, 2007
Non-Final Action Written
Jun 12, 2007
Assigned To Examiner
Apr 23, 2007
Amendment From Applicant Entered
Apr 23, 2007
Correspondence Received In Law Office
Apr 20, 2007
Paper Received
Mar 29, 2007
Report Completed Suspension Check Case Still Suspended
Mar 29, 2007
Assigned To Lie
Sep 10, 2006
Letter Of Suspension E-Mailed
Sep 10, 2006
Suspension Letter Written
Jun 29, 2006
Amendment From Applicant Entered
Jun 19, 2006
Correspondence Received In Law Office
Jun 19, 2006
Paper Received
Dec 19, 2005
Non-Final Action E-Mailed
Dec 19, 2005
Non-Final Action Written
Dec 9, 2005
Assigned To Examiner
May 20, 2005
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
